COMMUNICATIONS
Table 1. Direct asymmetric aldol reactions of 2 with aldehydes by chiral
phase-transfer catalysis of 1.[a]
Experimental Section
Aqueous NaOH (1%; 2.4 mL) was added at 08C under an argon
atmosphere to a solution of tert-butyl glycinate benzophenone Schiff base
2 (88.6 mg, 0.3 mmol) and (R,R)-1b (9.9 mg, 2 mol%) in toluene (3.0 mL),
and 3-phenylpropanal (79.0 mL, 0.6 mmol) was introduced dropwise. The
whole mixture was stirred for 2 h at 08C, and water and diethyl ether were
then added. The ether phase was separated and washed with brine. The
organic phase was dried over Na2SO4 and concentrated. The crude product
was dissolved in THF (8.0 mL) and treated with HCl (1.0n, 1.0 mL) at 08C
for 1 h. After removal of THF in vacuo, the aqueous solution was washed
with diethyl ether three times and neutralized with NaHCO3. The mixture
was then extracted with CH2Cl2 three times. The combined extracts were
dried over MgSO4 and concentrated. Purification of the residue by column
chromatography on silica gel with MeOH/CH2Cl2 (1:15) as eluent afforded
the corresponding b-hydroxy-a-amino ester 3 (R ¼ PhCH2CH2) (56.8 mg,
0.214 mmol, 71%, anti/syn 12:1). anti-3 (R ¼ PhCH2CH2): 1H NMR
(400 MHz, CDCl3): d ¼ 7.30 7.26 (m, 2H; Ph), 7.22 7.16 (m, 3H; Ph), 3.77
(ddd, J ¼ 3.2, 4.4, 10.0 Hz, 1H; CHOH), 3.47 (d, J ¼ 4.4 Hz, 1H; CHNH2),
2.91 2.84 (ddd, J ¼ 4.8, 9.2, 13.6 Hz, 1H; PhCH), 2.73 2.65 (ddd, J ¼ 8.0,
8.0, 13.6 Hz, 1H; PhCH), 1.85 (br s, 3H; OH and NH2), 1.75 1.65 (m, 1H;
PhCH2CH), 1.62 1.53 (m, 1H; PhCH2CH), 1.41 ppm (s, 9H; tBu). syn-3
(R ¼ PhCH2CH2): d ¼ 7.29 7.25 (m, 2H; Ph), 7.22 7.16 (m, 3H; Ph), 3.70
(ddd, J ¼ 4.8, 5.2, 7.6 Hz, 1H; CHOH), 3.24 (d, J ¼ 5.2 Hz, 1H; CHNH2),
2.90 2.82 (ddd, J ¼ 6.2, 9.0, 13.6 Hz, 1H; PhCH), 2.74 2.67 (ddd, J ¼ 7.2,
8.8, 13.6 Hz, 1H; PhCH), 2.17 (br s, 3H; OH and NH2), 1.85 1.78 (m, 2H;
PhCH2CH2), 1.46 ppm (s, 9H; tBu). The enantiomeric excess of the major
anti isomer was determined to be 96% by HPLC analysis of its N-benzoate:
chiral column, DAICEL Chiralcel OD-H, hexane/2-propanol (20:1), flow
Entry
R
Catalyst Yield [%][b] anti/syn[c] ee [%][d]
1
2
3
4
5
6
7
8
9
PhCH2CH2
PhCH2CH2
CH3(CH2)4CH2
iPr3SiOCH2
¼
1a
1b
1b
1b
76
71
65
72
62
71
58
40
78
3.3:1
12:1
10:1
20:1
6.3:1
2.4:1
2.3:1
2.8:1
1.2:1
91
96
91
98
80
90
92[e]
95
93[f]
CH2 CHCH2CH2 1b
CH2 CHCH2CH2 1a
¼
CH3
c-C6H11
c-C6H11
1a
1a
1a
[a] Unless otherwise specified, the reaction was carried out with 2 equivof
aldehyde in the presence of (R,R)-1 (2 mol%) in toluene/aqueous NaOH
(1%) at 08C for 2 h. [b] Yield of isolated product. [c] Determined by
1H NMR analysis. [d] Enantiomeric excess of anti-3, which was determined
by HPLC analysis of its N-benzoate by using a chiral column (DAICEL
Chiralcel OD-H) with hexane/2-propanol or hexane/ethanol as solvent.
[e] The reaction with (S,S)-1a as catalyst displayed similar reactivity and
selectivity. [f] Use of dibutyl ether as solvent.
enzymatic stability and enhanced drug transport activity.[16]
The reaction with a-triisopropylsiloxyacetaldehyde cleanly
produced the desired b-hydroxy-a-amino ester 3 (R ¼ iPr3-
SiOCH2) in 72% yield with virtually complete stereochemical
control (anti/syn 20:1; 98% ee) (Table 1, entry 4), which
parallels the l-threonine aldolase catalyzed aldol reaction
used for the synthesis of the monobactam antibiotic caruno-
man and its analogues.[12b] Moreover, a key building block for
the synthesis of the carbacephem antibiotic loracarbef,
previously prepared by a chemoenzymatic process with serine
hydroxymethyltransferase (SHMT),[12f] was readily assembled
with 4-pentenal as acceptor; (R,R)-1a resulted in a higher
enantioselectivity than did (R,R)-1b (Table 1, entries 5 and 6).
We also found that l-allo-threonine tert-butyl ester can be
obtained by the reaction of 2 with acetaldehyde in the
presence of (R,R)-1a, which confirmed that the absolute
configuration of the newly created a stereocenter is S
(Table 1, entry 7).[17] This method allows a facile preparation
of non-natural d-allo-threonine because of the ready avail-
ability of the enantiomerically pure catalyst (S,S)-1a. Inter-
estingly, (R,R)-1a was also a suitable catalyst for the reaction
with a-substituted aldehydes such as cyclohexanecarbalde-
hyde as acceptor; to attain sufficient reactivity, dibutyl ether
was used as solvent (Table 1, entries 8 and 9).
In summary, the direct asymmetric aldol reaction of glycine
Schiff base 2 with aldehyde acceptors proceeds under mild
organic/aqueous biphasic conditions with excellent stereo-
chemical control by using chiral quaternary ammonium salts
as catalysts. This reaction offers a powerful chemical method
for the synthesis of optically active b-hydroxy-a-amino acids,
and complements the aldolase-based chemoenzymatic proc-
esses. Therefore, the present system can be regarded as an
artificial glycine-dependent aldolase; its operational simplic-
ity, environmentally friendly conditions, and suitability for
large-scale reaction represent distinct advantages for practical
industrial applications.
rate ¼ 0.5 mLminꢀ1
,
retention times 23.06 min (minor) and 39.79 min
(major).
Received: July 16, 2002 [Z19746]
[1] a) Glycopeptide Antibiotics (Ed.: R. Nagarajan), Marcel-Dekker,
New York, 1994; b) Amino Acids, Peptides and Proteins; Special
Periodical Reports; Vols. 1 28, Chemistry Society, London, 1968
1995; c) M. A. Blaskovich, G. Evindar, N. G. W. Rose, S. Wilkinson, Y.
Luo, G. A. Lajoie, J. Org. Chem. 1998, 63, 3631, and references
therein.
[2] a) G. M. Coppola, H. F. Schuster, Asymmetric Synthesis: Construction
of Chiral Molecules Using Amino Acids, Wiley, Toronto, 1987; b) A.
Goleciowski, J. Jurczak, Synlett 1993, 241; c) J.-P. Genet, Pure Appl.
Chem. 1996, 68, 593.
[3] M. J. Miller, Acc. Chem. Res. 1986, 19, 49.
[4] a) S. V. Pansare, J. C. Vederas, J. Org. Chem. 1987, 52, 4804; b) R.
Badorrey, C. Cativiela, M. D. Diaz-de-Villegas, J. A. Galvez, Tetrahe-
dron: Asymmetry 2000, 11, 1015.
[5] D. Tanner, Angew. Chem. 1994, 106, 625; Angew. Chem. Int. Ed. Engl.
1994, 33, 599.
[6] For recent examples, see: a) A. M. P. Koskinen, H. Hasilla, V. T.
Myllymaki, K. Rissanen, Tetrahedron Lett. 1995, 36, 5619; b) H. Shao,
M. Goodman, J. Org. Chem. 1996, 61, 2582; c) T. Nagamitsu, T.
Sunazuka, H. Tanaka, S. Omura, P. A. Sprengeler, A. B. Smith III. , J.
Am. Chem. Soc. 1996, 118, 3584; d) C. Cativiela, M. D. Diaz-de-
Villegas, J. A. Galvez, J. I. Garcia, Tetrahedron 1996, 52, 9563; e) M.
Horikawa, Y. Shigeri, N. Yumoto, S. Yoshikawa, T. Nakajima, Y.
Ohfune, Bioorg. Med. Chem. Lett. 1998, 8, 2027; f) C. A. Hutton, Org.
Lett. 1999, 1, 295; g) P. D. Felice, G. Porzi, S. Sandri, Tetrahedron:
Asymmetry 1999, 10, 2191.
[7] With enolates of glycine derivatives: a) S. Kanemasa, T. Mori, A.
Tatsukawa, Tetrahedron Lett. 1993, 34, 8293; b) Y. N. Belokon, K. A.
Kochetkov, N. S. Ikonnikov, T. V. Strelkova, S. R. Harutyunyan, A. S.
Saghiyan, Tetrahedron: Asymmetry 2001, 12, 481; c) J. B. MacMillan,
T. F. Molinski, Org. Lett. 2002, 4, 1883.
[8] For a few examples in which a catalytic amount of chiral sources is
employed, see: a) Y. Ito, M. Sawamura, E. Shirakawa, K. Hayashizaki,
T. Hayashi, Tetrahedron 1988, 44, 5253; b) H. Suga, K. Ikai, T. Ibata,
Tetrahedron Lett. 1998, 39, 869; c) D. A. Evans, J. M. Janey, N.
Magomedov, J. S. Tedrow, Angew. Chem. 2001, 113, 1936; Angew.
Chem. Int. Ed. 2001, 40, 1884.
[9] For a recent review on the direct catalytic asymmetric aldol reaction,
see: a) B. Alcaide, P. Almendros, Eur. J. Org. Chem. 2002, 1595; see
Angew. Chem. Int. Ed. 2002, 41, No. 23
¹ 2002 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
0044-8249/02/4123-4543 $ 20.00+.50/0
4543